Company / Shares Outstanding
RAPT Therapeutics, Inc. Shares Outstanding History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
40.8M
FY2024
5-year range
24.1M / 40.8M
FY2020-FY2024
Trend
+6.3%
vs FY2023
Sector context
#176 of 208
Health Care
What the data says
RAPT Therapeutics, Inc.'s shares outstanding of 40761143.00 is lower than 85% of companies in the Health Care sector (FY2024). Shares Outstanding has increased for 6 consecutive years, from 622289.00 in FY2018 to 40761143.00 in FY2024.
Based on SEC 10-K filings.
40761143.00 in FY2024 with a 5-year CAGR of +56.5%.
Increased from 32540406.00 to 40761143.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +14.2%
- 5-Year CAGR
- +56.5%
- 10-Year CAGR
- -
Sector benchmark
-86.9% below sector average
Key checks
Key Insights
- RAPT Therapeutics, Inc.'s shares outstanding has grown for 6 consecutive years.
- In FY2024, shares outstanding increased 6.3% year-over-year.
- Ranks #176 out of 208 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 0.38 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 40.8M | +6.3% |
| FY2023 | 38.3M | +17.8% |
| FY2022 | 32.5M | +18.8% |
| FY2021 | 27.4M | +13.5% |
| FY2020 | 24.1M | +455.3% |
| FY2019 | 4.3M | +598.5% |
| FY2018 | 622.3K | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026